Development and prevention of postsurgical adhesions in a chimeric mouse model of experimental endometriosis

Condition tags

MeSH descriptors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (35)

• Antiangiogenic Agents Are Effective Inhibitors of Endometriosis via openalex
• Barrier agents for adhesion prevention after gynaecological surgery via openalex
• Dioxin may promote inflammation-related development of endometriosis via openalex
• Down-Regulation of Endometrial Matrix Metalloproteinase-3 and -7 Expression<i>in Vitro</i>and Therapeutic Regression of Experimental Endometriosis<i>in Vivo</i>by a Novel Nonsteroidal Progesterone Receptor Agonist, Tanaproget via openalex
• Endometriosis via openalex
• Matrix Metalloproteinases and Endometriosis via openalex
• Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis via openalex
• Reduced progesterone action during endometrial maturation: A potential risk factor for the development of endometriosis via openalex
• Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex
• W2052473036 via openalex
• W2055336549 via openalex
• W2066727139 via openalex
• W2067201007 via openalex
• W2067403798 via openalex
• W2080708223 via openalex
• W2090924501 via openalex
• W2093135399 via openalex
• W2095860426 via openalex
• W2103983153 via openalex
• W2140916223 via openalex
• W2245102765 via openalex
• W2402409175 via openalex
• W2614331021 via openalex
• W4252915939 via openalex
• W6642579691 via openalex
• W6658985193 via openalex
• W6690362910 via openalex
• W1633340712 via openalex
• W1969476201 via openalex
• W1978233255 via openalex
• W1998418707 via openalex
• W2013721469 via openalex
• W2022373151 via openalex
• W2034126825 via openalex
• W2048122282 via openalex

Cited by (33)

• WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Heterologous): heterologous rodent models 2025
• Identification of Potential Differentially Methylated Gene-Related Biomarkers in Endometriosis 2022
• Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis 2022
• PPARγ Agonists: Emergent Therapy in Endometriosis 2021
• A mouse model of endometriosis that displays vaginal, colon, cutaneous, and bladder sensory comorbidities 2021
• Endometriosis-Associated Pain – Do Preclinical Rodent Models Provide a Good Platform for Translation? 2020
• Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets 2018
• From pathogenesis to clinical practice: Emerging medical treatments for endometriosis 2018
• Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis 2018
• Novel Drug Targets with Traditional Herbal Medicines for Overcoming Endometriosis 2018
• Trauma and endometriosis. A review. May we explain surgical phenotypes and natural history of the disease? 2017
• New developments in the medical treatment of endometriosis 2017
• Looking Into Adhesion Formation and Its Relationship With Endometriosis 2017
• Laparoscopic Surgery: A New Technique to Induce Endometriosis in a Mouse Model 2016
• Endometriosis: where are we and where are we going? 2016
• Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models 2016
• Developmental Toxicant Exposure Is Associated with Transgenerational Adenomyosis in a Murine Model 2016
• Seminal Plasma Promotes Lesion Development in a Xenograft Model of Endometriosis 2015
• C-Jun NH2-Terminal Kinase and p38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis 2015
• Endometriosis adhesions formation and their prevention (a review) 2015
• Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-  by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions 2014
• Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturation 2013
• PPARγ Activation Inhibits Growth and Survival of Human Endometriotic Cells by Suppressing Estrogen Biosynthesis and PGE2 Signaling. 2013
• Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology. 2013
• Endometriosis and Immunology 2013
• Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress 2012
• New trends for the medical treatment of endometriosis 2012
• Dietary fish oil supplementation inhibits formation of endometriosis-associated adhesions in a chimeric mouse model 2012
• Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
• Peroxisome proliferating activating receptor gamma–independent attenuation of interleukin 6 and interleukin 8 secretion from primary endometrial stromal cells by thiazolidinediones 2011
• The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis 2011
• Immune interactions in endometriosis 2011
• Novel Therapies Targeting Endometriosis 2011

Source provenance

europepmc

last seen: 2026-06-11T06:19:48.454388+00:00

openalex

last seen: 2026-06-04T00:00:01.174412+00:00

pubmed

last seen: 2026-05-13T22:17:00.782903+00:00